This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1985 Sep 15;34(18):3395-8.

doi: 10.1016/0006-2952(85)90368-5.

Initial mechanistic studies with merbarone (NSC 336628)

D A Cooney, J M Covey, G J Kang, M Dalal, J B McMahon, D G Johns

PMID: 3840022
DOI: 10.1016/0006-2952(85)90368-5

Initial mechanistic studies with merbarone (NSC 336628)

D A Cooney et al. Biochem Pharmacol. 1985.

. 1985 Sep 15;34(18):3395-8.

doi: 10.1016/0006-2952(85)90368-5.

Authors

D A Cooney, J M Covey, G J Kang, M Dalal, J B McMahon, D G Johns

PMID: 3840022
DOI: 10.1016/0006-2952(85)90368-5

No abstract available

PubMed Disclaimer

Similar articles

Inhibition of macromolecular synthesis in L1210 mouse leukemia ascites cells by hycanthone.
Wilson RG, Bodner RH, Macwhorter GE. Wilson RG, et al. Biochim Biophys Acta. 1975 Jan 20;378(2):260-8. doi: 10.1016/0005-2787(75)90114-8. Biochim Biophys Acta. 1975. PMID: 1125230
Prostaglandin D2, a potential antineoplastic agent.
Fukushima M, Kato T, Ueda R, Ota K, Narumiya S, Hayaishi O. Fukushima M, et al. Biochem Biophys Res Commun. 1982 Apr 14;105(3):956-64. doi: 10.1016/0006-291x(82)91063-4. Biochem Biophys Res Commun. 1982. PMID: 6953969 No abstract available.
Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism.
Hall IH, Taylor K, Izydore RA, Daniels DL. Hall IH, et al. Pharmazie. 1998 Nov;53(11):794-9. Pharmazie. 1998. PMID: 9853360 No abstract available.
A modified screening system to select new cytostatic drugs.
Kraemer HP, Sedlacek HH. Kraemer HP, et al. Behring Inst Mitt. 1984 May;(74):301-28. Behring Inst Mitt. 1984. PMID: 6383326 Review. No abstract available.
Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
Catsoulacos P, Catsoulacos D. Catsoulacos P, et al. Anticancer Res. 1994 Nov-Dec;14(6B):2525-8. Anticancer Res. 1994. PMID: 7872677 Review.

See all similar articles

Cited by

DNA cleavage and Trp53 differentially affect SINE transcription.
Hagan CR, Rudin CM. Hagan CR, et al. Genes Chromosomes Cancer. 2007 Mar;46(3):248-60. doi: 10.1002/gcc.20406. Genes Chromosomes Cancer. 2007. PMID: 17171681 Free PMC article.
Nephrotoxicity of 5-(N-phenylcarboxamido)-2-thiobarbituric acid in the Fischer 344 rat.
Nakagawa Y, Kramer RA. Nakagawa Y, et al. Cancer Chemother Pharmacol. 1989;25(2):109-13. doi: 10.1007/BF00692349. Cancer Chemother Pharmacol. 1989. PMID: 2598397
Merbarone: an antitumor agent entering clinical trials.
Glover A, Chun HG, Kleinman LM, Cooney DA, Plowman J, Grieshaber CK, Malspeis L, Leyland-Jones B. Glover A, et al. Invest New Drugs. 1987;5(2):137-43. doi: 10.1007/BF00203538. Invest New Drugs. 1987. PMID: 3308762 Review.
Phase II trial of merbarone in soft tissue sarcoma. A Southwest Oncology Group study.
Kraut EH, Bendetti J, Balcerzak SP, Doroshow JH. Kraut EH, et al. Invest New Drugs. 1992 Nov;10(4):347-9. doi: 10.1007/BF00944194. Invest New Drugs. 1992. PMID: 1487411 Clinical Trial.
Phase II evaluation of merbarone in renal cell carcinoma.
Flanigan RC, Saiers JH, Wolf M, Kraut EH, Smith AY, Blumenstein B, Crawford ED. Flanigan RC, et al. Invest New Drugs. 1994;12(2):147-9. doi: 10.1007/BF00874446. Invest New Drugs. 1994. PMID: 7860233 Clinical Trial.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science